昂利康(002940.SZ)：西格列汀二甲双胍缓释片完成药品注册

Group 1 - The company, Anglikang (002940.SZ), has received the drug registration certificate for Sitagliptin Metformin Extended-Release Tablets from the National Medical Products Administration [1] - Sitagliptin Metformin Extended-Release Tablets are a compound preparation suitable for adult patients with type 2 diabetes who are currently receiving combined treatment with Sitagliptin and Metformin Extended-Release Tablets [1]